학술논문

3′-Deoxy-3’-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies
Document Type
Article
Source
In: European Journal of Nuclear Medicine and Molecular Imaging. (European Journal of Nuclear Medicine and Molecular Imaging, 1 July 2019, 46(8):1713-1722)
Subject
Language
English
ISSN
16197089
16197070